Silver Book reference

Cost-Effectiveness of Pneumococcal Conjugate Vaccination in Immunocompromised Adults

1 Matching Fact

Search matching Facts:
No results to display
    • Cost of pneumonia vaccine
      Addition of PCV13 (13-valent pneumococcal conjugate vaccine) to previously recommended pneumococcal polysaccharide vaccine for immunocompromised adults cost $70,937 per quality adjusted life year compared to no vaccine.